Page last updated: 2024-11-04

succinylacetone and Renal Insufficiency

succinylacetone has been researched along with Renal Insufficiency in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruneau, N1
St-Vil, D1
Luks, FI1
LaBerge, JM1
Bensoussan, AL1
Blanchard, H1

Other Studies

1 other study available for succinylacetone and Renal Insufficiency

ArticleYear
[Surgical and metabolic aspects of liver transplantation for tyrosinemia].
    Annales de chirurgie, 1993, Volume: 47, Issue:9

    Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Central Nervous System Diseas

1993